Published in Brain Res on July 11, 1975
Noradrenaline-mediated synaptic inhibition in rat locus coeruleus neurones. J Physiol (1983) 1.49
Plateau potentials in alpha-motoneurones induced by intravenous injection of L-dopa and clonidine in the spinal cat. J Physiol (1988) 1.42
Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci (1991) 1.36
Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Curr Neuropharmacol (2008) 1.34
Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms. Br J Pharmacol (1987) 1.24
The locus coeruleus and central chemosensitivity. Respir Physiol Neurobiol (2010) 1.03
Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. J Psychiatry Neurosci (2009) 1.01
Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder. CNS Neurosci Ther (2010) 1.01
Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale. Yale J Biol Med (2012) 0.99
Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. J Clin Invest (1988) 0.95
The effects of clonidine premedication and scalp infiltration of lidocaine on hemodynamic responses to laryngoscopy and skull pin head-holder insertion during skull base procedures. Skull Base (2001) 0.95
Long latency of evoked quantal transmitter release from somata of locus coeruleus neurons in rat pontine slices. Proc Natl Acad Sci U S A (2007) 0.94
Facilitatory influence of noradrenergic afferents on the excitability of rat paraventricular nucleus neurosecretory cells. J Physiol (1984) 0.93
Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response. J Psychiatry Neurosci (2004) 0.90
Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex. Psychopharmacology (Berl) (2011) 0.89
Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons. Neuropharmacology (2012) 0.89
The Effects of Stress Exposure on Prefrontal Cortex: Translating Basic Research into Successful Treatments for Post-Traumatic Stress Disorder. Neurobiol Stress (2015) 0.87
A hidden Markov model approach to neuron firing patterns. Biophys J (1996) 0.85
Bioaminergic neuromodulation of respiratory rhythm in vitro. Respir Physiol Neurobiol (2009) 0.85
Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe. Proc Natl Acad Sci U S A (2013) 0.83
Effects of the noradrenergic agonist clonidine on temporal and spatial attention. Psychopharmacology (Berl) (2007) 0.83
Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex. Br J Pharmacol (2001) 0.82
Some electrophysiological properties of neurones of rat locus coeruleus. J Physiol (1977) 0.82
Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion. Neurochem Res (2009) 0.82
Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by alpha2-adrenoceptors. Br J Pharmacol (1999) 0.82
Gilles de la Tourette syndrome: a review. J R Soc Med (1986) 0.82
Glutamate-induced post-activation inhibition of locus coeruleus neurons is mediated by AMPA/kainate receptors and sodium-dependent potassium currents. Br J Pharmacol (2009) 0.81
Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Psychopharmacology (Berl) (2003) 0.80
Noradrenergic modulation of risk/reward decision making. Psychopharmacology (Berl) (2015) 0.79
The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain. Psychopharmacology (Berl) (2011) 0.79
The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse. Br J Pharmacol (1993) 0.78
Prenatal cocaine exposure enhances responsivity of locus coeruleus norepinephrine neurons: role of autoreceptors. Neuroscience (2007) 0.78
Comparison of medetomidine and fentanyl-droperidol in dogs: sedation, analgesia, arterial blood gases and lactate levels. Can J Vet Res (1993) 0.78
Serotonergic mechanisms on breathing modulation in the rat locus coeruleus. Pflugers Arch (2009) 0.78
Involvement of serotonin 5-HT3 receptors in the modulation of noradrenergic transmission by serotonin reuptake inhibitors: a microdialysis study in rat brain. Psychopharmacology (Berl) (2013) 0.78
Alprazolam potentiates the antiaversive effect induced by the activation of 5-HT(1A) and 5-HT (2A) receptors in the rat dorsal periaqueductal gray. Psychopharmacology (Berl) (2008) 0.77
Spinal and supraspinal functions of noradrenaline in the frog embryo: consequences for motor behaviour. J Physiol (2003) 0.77
Physiology of quantal norepinephrine release from somatodendritic sites of neurons in locus coeruleus. Front Mol Neurosci (2012) 0.77
Harmane inhibits serotonergic dorsal raphe neurons in the rat. Psychopharmacology (Berl) (2005) 0.77
Modulation of L-DOPA's antiparkinsonian and dyskinetic effects by α2-noradrenergic receptors within the locus coeruleus. Neuropharmacology (2015) 0.76
Biochemical pharmacology of paradoxical sleep. Br J Clin Pharmacol (1983) 0.76
Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study. Int J Neuropsychopharmacol (2015) 0.75
Cannabis, catecholamines, rapid eye movement sleep and aggressive behaviour. Br J Pharmacol (1977) 0.75
Pharmacologic Evaluation of Antidepressant Activity and Synthesis of 2-Morpholino-5-phenyl-6H-1,3,4-thiadiazine Hydrobromide. Pharmaceuticals (Basel) (2016) 0.75
Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats. J Neural Transm (Vienna) (2004) 0.75
Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol (1989) 4.96
The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci (1984) 4.52
Molecular and cellular basis of addiction. Science (1997) 3.57
Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry (1990) 3.57
Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization. Neuroscience (1983) 3.09
The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci (1984) 2.99
Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature (1978) 2.85
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse (1987) 2.20
Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther (1973) 2.05
The formation of synaptic junctions in developing rat brain: a quantitative electron microscopic study. Brain Res (1967) 1.90
Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res (1983) 1.82
Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse (1994) 1.66
Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats. Respiration (2002) 1.66
alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science (1982) 1.65
Carbon dioxide regulates the tonic activity of locus coeruleus neurons by modulating a proton- and polyamine-sensitive inward rectifier potassium current. Neuroscience (1997) 1.63
Physiological evidence for habenula as major link between forebrain and midbrain raphe. Science (1977) 1.61
Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat New Biol (1973) 1.61
Prefrontal cortical network activity: Opposite effects of psychedelic hallucinogens and D1/D5 dopamine receptor activation. Neuroscience (2007) 1.59
Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther (2000) 1.58
Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand (1986) 1.57
Fine structural and cytochemical analysis of the staining of synaptic junctions with phosphotungstic acid. J Ultrastruct Res (1968) 1.56
Effects of amphetamine on single cell activity in a catecholamine nucleus, the locus coeruleus. Nature (1971) 1.55
Selective reduction of tryptophan hydroxylase activity in rat forebrain after midbrain raphe lesions. Brain Res (1971) 1.54
Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur J Neurosci (1993) 1.54
Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci U S A (1996) 1.49
Serotonin receptors in the brain. Fed Proc (1977) 1.46
Choline: selective accumulation by central cholinergic neurons. J Neurochem (1973) 1.45
Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry (1996) 1.41
Serotonergic facilitation of facial motoneuron excitation. Brain Res (1979) 1.41
Modulation of a transient outward current in serotonergic neurones by alpha 1-adrenoceptors. Nature (1985) 1.40
Dopamine"autoreceptors": pharmacological characterization by microiontophoretic single cell recording studies. Naunyn Schmiedebergs Arch Pharmacol (1977) 1.39
Active immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell. Respiration (2002) 1.39
Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett (1993) 1.39
CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci (1997) 1.38
Cytochemistry of synapses: selective staining for electron microscopy. Science (1966) 1.38
Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci (1996) 1.38
Intracellular studies showing modulation of facial motoneurone excitability by serotonin. Nature (1980) 1.36
Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J Neurosci (1990) 1.34
Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci (1997) 1.33
Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm Gen Sect (1993) 1.32
Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra. Brain Res (1978) 1.32
Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J Comp Neurol (1978) 1.31
Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Eur J Pharmacol (1977) 1.31
Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence. Science (1980) 1.28
Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors. J Neurosci (2000) 1.28
Hypercapnia and hypoxia: chemoreceptor-mediated control of locus coeruleus neurons and splanchnic, sympathetic nerves. Brain Res (1981) 1.28
Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology (1980) 1.27
5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacol (1999) 1.26
Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci (1983) 1.26
Dopamine and norepinephrine innervated cells in the rat prefrontal cortex: pharmacological differentiation using microiontophoretic techniques. Life Sci (1976) 1.25
An investigation of a new instrument to measure motor activity of small animals. Psychopharmacologia (1969) 1.24
Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of alpha7 nicotinic receptors in the ventral tegmental area. Neuroscience (1998) 1.24
Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--2. Action potential generating mechanisms and morphological correlates. Neuroscience (1983) 1.23
Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience (1984) 1.22
Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Brain Res (1998) 1.21
Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur J Pharmacol (1974) 1.21
Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience (1999) 1.21
Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in brain: putative implications for psychiatry and psychopharmacology. Psychopharmacology (Berl) (1987) 1.21
Action of psychotogenic drugs on single midbrain raphe neurons. J Pharmacol Exp Ther (1970) 1.20
Lysergic acid diethylamide and serotonin: direct actions on serotonin-containing neurons in rat brain. Life Sci I (1972) 1.20
Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J Pharmacol Exp Ther (1986) 1.19
Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists. Science (1979) 1.19
5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci (1997) 1.19
Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol (1993) 1.19
Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology (1988) 1.19
Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol Toxicol (1994) 1.18
Pertussis toxin blocks the outward currents evoked by opiate and alpha 2-agonists in locus coeruleus neurons. Brain Res (1986) 1.18
Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J Neurochem (1989) 1.18
Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res (1985) 1.17
Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci (1978) 1.17
Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the alpha-antagonist piperoxane. Brain Res (1976) 1.17
Opiate- and alpha 2-adrenoceptor-induced hyperpolarizations of locus ceruleus neurons in brain slices: reversal by cyclic adenosine 3':5'-monophosphate analogues. J Neurosci (1985) 1.17
Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. Eur J Pharmacol (1979) 1.16
On the mode of action of amantadine. J Pharm Pharmacol (1970) 1.16
Intracellular identification of central noradrenergic and serotonergic neurons by a new double labeling procedure. J Neurosci (1982) 1.16
Hyperpolarization of serotonergic neurons by serotonin and LSD: studies in brain slices showing increased K+ conductance. Brain Res (1984) 1.16
Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe. Science (1968) 1.16
Prazosin selectively antagonizes neuronal responses mediated by alpha1-adrenoceptors in brain. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.16
The role of Kv1.2-containing potassium channels in serotonin-induced glutamate release from thalamocortical terminals in rat frontal cortex. J Neurosci (2001) 1.16
Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons. Brain Res (1977) 1.16
Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry (1994) 1.16
Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem (1990) 1.15
Noradrenergic innervation of serotonergic neurons in the dorsal raphe: demonstration by electron microscopic autoradiography. Brain Res (1981) 1.15
Repetitive firing properties of putative dopamine-containing neurons in vitro: regulation by an apamin-sensitive Ca(2+)-activated K+ conductance. Exp Brain Res (1991) 1.14
Firing properties of substantia nigra dopaminergic neurons in freely moving rats. Life Sci (1985) 1.13
The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiatry Clin Neurosci (1997) 1.13
On the significance of central noradrenaline for motor activity: experiments with a new dopamine beta-hydroxylase inhibitor. Eur J Pharmacol (1969) 1.13
Molecular and cellular mechanisms of opiate action: studies in the rat locus coeruleus. Brain Res Bull (1994) 1.12
Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--3. Evidence for electrotonic coupling. Neuroscience (1983) 1.11
Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Res (1997) 1.10
Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: alpha-receptor mediation. Science (1978) 1.09
Habenular and other midbrain raphe afferents demonstrated by a modified retrograde tracing technique. Brain Res (1977) 1.09
Putative role of presynaptic alpha7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area. Synapse (2000) 1.08
Pacemaker potentials of serotonergic dorsal raphe neurons: contribution of a low-threshold Ca2+ conductance. Synapse (1987) 1.08